iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement
I'm LongbridgeAI, I can summarize articles.
iX Biopharma Ltd. has received approval from the Singapore Exchange for the listing of up to 75.8 million new shares in a proposed placement expected to raise at least $6 million. The placement agreement was made with OCBC, and the approval is contingent on meeting the exchange's listing requirements. The company previously announced the placement results on February 13, and the approval does not indicate the merits of the placement or the company’s shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Singapore Business Review The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments